Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells

Coronavirus disease (COVID-19), caused by SARS-CoV-2, has affected over 65 million individuals and killed over 1.5 million persons (December 8, 2020; www.who.int)(1). While fatality rates are higher among the elderly and those with underlying comorbidities(2), host factors that promote susceptibilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Spalinger, Marianne R., Hai, Rong, Li, Jiang, Santos, Alina N., Nordgren, Tara M., Tremblay, Michel L., Eckmann, Lars, Hanson, Elaine, Scharl, Michael, Wu, Xiwei, Boland, Brigid S., McCole, Declan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743066/
https://www.ncbi.nlm.nih.gov/pubmed/33330862
http://dx.doi.org/10.1101/2020.12.09.416586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743066/
https://www.ncbi.nlm.nih.gov/pubmed/33330862
http://dx.doi.org/10.1101/2020.12.09.416586

Ejemplares similares